Tesamorelin shortage status
1 active shortage notice across 1 country.
Last updated 25 May 2026 · sourced from official medicines regulators
- Generic name (INN)
- Tesamorelin
- Class
- Auto-created by FDA Drug Enforcement — Full Recall Database scraper
Where Tesamorelin is in shortage
| Country | Severity | Notices | Since | Est. resolution | Source |
|---|---|---|---|---|---|
| United States | high | 1 | 30 Jul 2025 | — | FDA MedWatch |
Why Tesamorelin is in shortage
- regulatory action — e.g. “Lack of Assurance of Sterility” (United States)
Frequently asked questions
Is Tesamorelin currently in shortage?
Yes. As of the latest regulator updates, Tesamorelin has 1 active shortage notice across 1 country (United States). Status is refreshed daily from official regulatory sources.
Why is Tesamorelin in shortage?
Regulators attribute the current Tesamorelin shortages to regulatory action. The exact cause varies by country and product — each notice on this page links to the official source.
Where does this Tesamorelin shortage data come from?
Every shortage notice on this page is scraped daily from an official national medicines regulator (such as the FDA, TGA, MHRA or EMA) and linked back to its source. Mederti aggregates 40+ regulators across 50+ countries and never publishes unsourced shortage claims.
Get alerted when Tesamorelin status changes
Free for individual pharmacists and clinicians — watchlists, email alerts, alternatives and country-by-country product detail.
Create a free accountData on this page is aggregated from official national medicines regulators and updated daily. It is provided for information only and requires verification before clinical use. Mederti is not affiliated with or endorsed by any regulator.